National Health (Weighted average disclosure price main disclosure cycle) Amendment Determination 2013 (No. 1) (No. PB 18 of 2013) (Cth)
PB 18 of 2013
National Health (Weighted average disclosure price – main disclosure cycle) Amendment Determination 2013 (No. 1)
National Health Act 1953
I, FELICTY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this determination under subsection 99ADB(4) of the National Health Act 1953.
Dated 7 March 2013
FELICTY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
Name of Determination
(1) This Determination is the National Health (Weighted average disclosure price – main disclosure cycle) Amendment Determination 2013 (No. 1).
(2) This Determination may also be cited as PB 18 of 2013.
Commencement
This Determination commences on the day after it is registered.
3 Amendments to PB 107 of 2012
Schedule 1 amends the National Health (Weighted average disclosure price – main disclosure cycle) Determination 2012 (PB 107 of 2012).
Schedule 1 Amendments
[1] Schedule 1
omit:
| 376 | Hydroxocobalamin | Injection 1 mg (as acetate) in 1 mL | Injection | Vita-B12 |
insert:
| 376 | Hydroxocobalamin | Injection 1 mg (as acetate) in 1 mL | Injection | Vita-B12 | 5.62 |
[2] Schedule 2, After
| 253 | Macrogol 3350 | Sachets containing powder for oral solution 13.125 g with electrolytes, 30 | Oral | Movicol | 11.38 |
insert:
| 253A | Macrogol 3350 | Sachets containing powder for oral solution 17 g, 30 | Oral | MediHealth ClearLax | 11.38 |
[3] Schedule 2, After
| 306 | Morphine | Injection containing morphine sulphate 10 mg in 1 mL | Injection | Hospira Pty Limited | 3.71 |
insert:
| 306A | Morphine | Injection containing morphine sulphate 10 mg in 1 mL (with preservative) | Injection | Morphine Sulphate Workhardt | 7.42 |
[4] Schedule 2
omit:
| 365 | Paraffin | Eye ointment, compound, containing liquid paraffin, light liquid paraffin, wool fat, white soft paraffin and retinyl palmitate, 5 g | Application to the eye | VitA-POS |
insert:
| 365 | Paraffin | Eye ointment, compound, containing liquid paraffin, light liquid paraffin, wool fat, white soft paraffin and retinyl palmitate, 5 g | Application to the eye | VitA-POS | 5.99 |
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See
0
0
0